SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,051 | -16.1% | 302,897 | +12.4% | 0.00% | 0.0% |
Q2 2023 | $1,253 | +109.5% | 269,497 | +108.3% | 0.00% | +100.0% |
Q1 2023 | $598 | +147.1% | 129,397 | +332.8% | 0.00% | – |
Q4 2022 | $242 | -100.0% | 29,900 | -86.2% | 0.00% | -100.0% |
Q3 2022 | $1,198,000 | +55.6% | 215,900 | +46.2% | 0.00% | +100.0% |
Q2 2022 | $770,000 | +6.2% | 147,700 | +203.3% | 0.00% | 0.0% |
Q4 2021 | $725,000 | +11.2% | 48,700 | +62.3% | 0.00% | 0.0% |
Q4 2020 | $652,000 | -43.8% | 30,014 | -79.9% | 0.00% | 0.0% |
Q2 2020 | $1,160,000 | +926.5% | 149,513 | +1351.6% | 0.00% | – |
Q4 2019 | $113,000 | – | 10,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |